1. Look at the massive Long-Term Debt... The only way they will sustain is to do another debt to equity swap. Hence, more dilution.
2. There is nothing on the pipeline. 2nd drug Roclatan also uses Rhopressa which we already know did not meet the primary endpoint.
3. CEO dumped before PR. This is huge. I wouldn't be surprised if SEC comes out with summon this week.
4. Litigation. Lawyers lining up for lawsuit.
Rophresa already failed.. The other drug which also uses Rophresa is next. Now tell me why I shouldn't dump this stock when there's nothing on the horizon but more liquidation. Y'all got crooked out by the CEO.
Sentiment: Strong Sell
Sending PPS to TEENS.